Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.

Amanda Nordigården, Jenny Zetterblad, Cecilia Trinks, Henrik Green, Pernilla Eliasson, Pia Druid, Kourosh Lotfi, Lars Rönnstrand, Thomas M Walz, Jan-Ingvar Jönsson

Research output: Contribution to journalArticlepeer-review

6 Citations (SciVal)

Fingerprint

Dive into the research topics of 'Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.'. Together they form a unique fingerprint.

Medicine & Life Sciences